Advertisement

Citation tools

Zeidner, Joshua F et al "Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)." Blood 132.Suppl 1 (2018): 30. Web. 19 June. 2019.